Dr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is on the faculty of the Stanford University School of Medicine, a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Board of Addiction Medicine. She is the Program Director for the Stanford University Addiction Medicine Fellowship, and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. She has published over 50 peer-reviewed articles, chapters, and commentaries, including in the New England Journal of Medicine, the Journal of the American Medical Association, the Journal of General Internal Medicine, and Addiction. Dr. Lembke sees patients, teaches, and does research. She is the author of a book on the prescription drug epidemic: “Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop” (Johns Hopkins University Press, October 2016).
Dr. Anna Lembke's key areas of interest include treating patients who have become addicted to prescription drugs. She takes a holistic, harm-reduction approach to each patient, and encourages spiritual and alternative therapies in the process of healing.
- Co-occurring addiction
- Addiction Medicine
Associate Professor - Med Center Line, Psychiatry and Behavioral Sciences
Associate Professor - Med Center Line (By courtesy), Anesthesiology, Perioperative and Pain Medicine
Internship:Alameda County Medical Center UCSF East Bay Surgical Residency (1998) CA
Residency:Stanford University School of Medicine Registrar (2001) CA
Residency:Stanford University School of Medicine Registrar (1997) CA
Board Certification: Addiction Medicine, American Board of Addiction Medicine (2012)
Medical Education:Stanford University School of Medicine (1995) CA
Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2003)